T-Cell Death-Associated Gene 51 Is a Novel Negative Regulator of PPARγ That Inhibits PPARγ-RXRα Heterodimer Formation in Adipogenesis |
Kim, Sumi
(Department of Microbiology and Molecular Biology, Chungnam National University)
Lee, Nari (Department of Microbiology and Molecular Biology, Chungnam National University) Park, Eui-Soon (Department of Microbiology and Molecular Biology, Chungnam National University) Yun, Hyeongseok (Department of Microbiology and Molecular Biology, Chungnam National University) Ha, Tae-Uk (Department of Microbiology and Molecular Biology, Chungnam National University) Jeon, Hyoeun (Department of Microbiology and Molecular Biology, Chungnam National University) Yu, Jiyeon (Department of Microbiology and Molecular Biology, Chungnam National University) Choi, Seunga (Department of Microbiology and Molecular Biology, Chungnam National University) Shin, Bongjin (Department of Microbiology and Molecular Biology, Chungnam National University) Yu, Jungeun (Department of Microbiology and Molecular Biology, Chungnam National University) Rhee, Sang Dal (Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology) Choi, Yongwon (Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine) Rho, Jaerang (Department of Microbiology and Molecular Biology, Chungnam National University) |
1 | Ahmadian, M., Suh, J.M., Hah, N., Liddle, C., Atkins, A.R., Downes, M., and Evans, R.M. (2013). PPARgamma signaling and metabolism: the good, the bad and the future. Nat. Med. 19, 557-566. DOI |
2 | Armoni, M., Harel, C., Karni, S., Chen, H., Bar-Yoseph, F., Ver, M.R., Quon, M.J., and Karnieli, E. (2006). FOXO1 represses peroxisome proliferatoractivated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. J. Biol. Chem. 281, 19881-19891. DOI |
3 | Basseri, S., Lhotak, S., Fullerton, M.D., Palanivel, R., Jiang, H., Lynn, E.G., Ford, R.J., Maclean, K.N., Steinberg, G.R., and Austin, R.C. (2013). Loss of TDAG51 results in mature-onset obesity, hepatic steatosis, and insulin resistance by regulating lipogenesis. Diabetes 62, 158-169. DOI |
4 | Burton, G.R., Nagarajan, R., Peterson, C.A., and McGehee, R.E., Jr. (2004). Microarray analysis of differentiation-specific gene expression during 3T3-L1 adipogenesis. Gene 329, 167-185. DOI |
5 | Chandra, V., Huang, P., Hamuro, Y., Raghuram, S., Wang, Y., Burris, T.P., and Rastinejad, F. (2008). Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature 456, 350-356. DOI |
6 | Chen, Y., Takikawa, M., Tsutsumi, S., Yamaguchi, Y., Okabe, A., Shimada, M., Kawase, T., Sada, A., Ezawa, I., Takano, Y., et al. (2018). PHLDA1, another PHLDA family protein that inhibits Akt. Cancer Sci. 109, 3532-3542. DOI |
7 | Dowell, P., Otto, T.C., Adi, S., and Lane, M.D. (2003). Convergence of peroxisome proliferator-activated receptor gamma and Foxo1 signaling pathways. J. Biol. Chem. 278, 45485-45491. DOI |
8 | Elberg, G., Gimble, J.M., and Tsai, S.Y. (2000). Modulation of the murine peroxisome proliferator-activated receptor γ2 promoter activity by CCAAT/enhancer-binding proteins. J. Biol. Chem. 275, 27815-27822. DOI |
9 | Fan, W., Imamura, T., Sonoda, N., Sears, D.D., Patsouris, D., Kim, J.J., and Olefsky, J.M. (2009). FOXO1 transrepresses peroxisome proliferatoractivated receptor gamma transactivation, coordinating an insulininduced feed-forward response in adipocytes. J. Biol. Chem. 284, 12188-12197. DOI |
10 | Fearon, A.E., Carter, E.P., Clayton, N.S., Wilkes, E.H., Baker, A.M., Kapitonova, E., Bakhouche, B.A., Tanner, Y., Wang, J., Gadaleta, E., et al. (2018). PHLDA1 mediates drug resistance in receptor tyrosine kinase-driven cancer. Cell Rep. 22, 2469-2481. DOI |
11 | Gehring, W.J., Affolter, M., and Burglin, T. (1994). Homeodomain proteins. Annu. Rev. Biochem. 63, 487-526. DOI |
12 | Hauser, S., Adelmant, G., Sarraf, P., Wright, H.M., Mueller, E., and Spiegelman, B.M. (2000). Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. J. Biol. Chem. 275, 18527-18533. DOI |
13 | Hayashida, N., Inouye, S., Fujimoto, M., Tanaka, Y., Izu, H., Takaki, E., Ichikawa, H., Rho, J., and Nakai, A. (2006). A novel HSF1-mediated death pathway that is suppressed by heat shock proteins. EMBO J. 25, 4773-4783. DOI |
14 | Hossain, G.S., Lynn, E.G., Maclean, K.N., Zhou, J., Dickhout, J.G., Lhotak, S., Trigatti, B., Capone, J., Rho, J., Tang, D., et al. (2013). Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expression. J. Am. Heart Assoc. 2, e000134. DOI |
15 | Hu, E., Kim, J.B., Sarraf, P., and Spiegelman, B.M. (1996). Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma. Science 274, 2100-2103. DOI |
16 | Iankova, I., Petersen, R.K., Annicotte, J.S., Chavey, C., Hansen, J.B., Kratchmarova, I., Sarruf, D., Benkirane, M., Kristiansen, K., and Fajas, L. (2006). Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis. Mol. Endocrinol. 20, 1494-1505. DOI |
17 | Kamata, M., Okitsu, Y., Fujiwara, T., Kanehira, M., Nakajima, S., Takahashi, T., Inoue, A., Fukuhara, N., Onishi, Y., Ishizawa, K., et al. (2014). GATA2 regulates differentiation of bone marrow-derived mesenchymal stem cells. Haematologica 99, 1686-1696. DOI |
18 | Jiao, H.W., Jia, X.X., Zhao, T.J., Rong, H., Zhang, J.N., Cheng, Y., Zhu, H.P., Xu, K.L., Guo, S.Y., Shi, Q.Y., et al. (2016). Up-regulation of TDAG51 is a dependent factor of LPS-induced RAW264.7 macrophages proliferation and cell cycle progression. Immunopharmacol. Immunotoxicol. 38, 124-130. DOI |
19 | Johnson, E.O., Chang, K.H., de Pablo, Y., Ghosh, S., Mehta, R., Badve, S., and Shah, K. (2011). PHLDA1 is a crucial negative regulator and effector of Aurora A kinase in breast cancer. J. Cell Sci. 124, 2711-2722. DOI |
20 | Juge-Aubry, C., Pernin, A., Favez, T., Burger, A.G., Wahli, W., Meier, C.A., and Desvergne, B. (1997). DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5'-flanking region. J. Biol. Chem. 272, 25252-25259. DOI |
21 | Kim, J.I., Kaufman, R.J., Back, S.H., and Moon, J.Y. (2019). Development of a reporter system monitoring regulated intramembrane proteolysis of the transmembrane bZIP transcription factor ATF6alpha. Mol. Cells 42, 783-793. DOI |
22 | Kim, T.H., Kim, H., Park, J.M., Im, S.S., Bae, J.S., Kim, M.Y., Yoon, H.G., Cha, J.Y., Kim, K.S., and Ahn, Y.H. (2009). Interrelationship between liver X receptor alpha, sterol regulatory element-binding protein-1c, peroxisome proliferator-activated receptor gamma, and small heterodimer partner in the transcriptional regulation of glucokinase gene expression in liver. J. Biol. Chem. 284, 15071-15083. DOI |
23 | Kroker, A.J. and Bruning, J.B. (2015). Review of the structural and dynamic mechanisms of PPARgamma partial agonism. PPAR Res. 2015, 816856. DOI |
24 | Nagai, M.A. (2016). Pleckstrin homology-like domain, family A, member 1 (PHLDA1) and cancer. Biomed. Rep. 4, 275-281. DOI |
25 | Lefterova, M.I. and Lazar, M.A. (2009). New developments in adipogenesis. Trends Endocrinol. Metab. 20, 107-114. DOI |
26 | Li, G., Wang, X., Hibshoosh, H., Jin, C., and Halmos, B. (2014). Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1. PLoS One 9, e106349. DOI |
27 | Miard, S. and Fajas, L. (2005). Atypical transcriptional regulators and cofactors of PPARgamma. Int. J. Obes. (Lond.) 29 Suppl 1, S10-S12. DOI |
28 | Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W.H., 3rd, Arden, K.C., and Accili, D. (2003). The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev. Cell 4, 119-129. DOI |
29 | Nishizawa, H., Yamagata, K., Shimomura, I., Takahashi, M., Kuriyama, H., Kishida, K., Hotta, K., Nagaretani, H., Maeda, N., Matsuda, M., et al. (2002). Small heterodimer partner, an orphan nuclear receptor, augments peroxisome proliferator-activated receptor gamma transactivation. J. Biol. Chem. 277, 1586-1592. DOI |
30 | Park, C.G., Lee, S.Y., Kandala, G., Lee, S.Y., and Choi, Y. (1996). A novel gene product that couples TCR signaling to Fas(CD95) expression in activation-induced cell death. Immunity 4, 583-591. DOI |
31 | Park, E.S., Choi, S., Shin, B., Yu, J., Hwang, J.M., Yun, H., Chung, Y.H., Choi, J.S., Choi, Y., and Rho, J. (2015). Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction. J. Biol. Chem. 290, 9660-9673. DOI |
32 | Qiao, L. and Shao, J. (2006). SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex. J. Biol. Chem. 281, 39915-39924. DOI |
33 | Park, E.S., Kim, J., Ha, T.U., Choi, J.S., Soo Hong, K., and Rho, J. (2013). TDAG51 deficiency promotes oxidative stress-induced apoptosis through the generation of reactive oxygen species in mouse embryonic fibroblasts. Exp. Mol. Med. 45, e35. DOI |
34 | Park, M.J., Kong, H.J., Kim, H.Y., Kim, H.H., Kim, J.H., and Cheong, J.H. (2007). Transcriptional repression of the gluconeogenic gene PEPCK by the orphan nuclear receptor SHP through inhibitory interaction with C/EBPalpha. Biochem. J. 402, 567-574. DOI |
35 | Pascual, G., Fong, A.L., Ogawa, S., Gamliel, A., Li, A.C., Perissi, V., Rose, D.W., Willson, T.M., Rosenfeld, M.G., and Glass, C.K. (2005). A SUMOylationdependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature 437, 759-763. DOI |
36 | Rosen, E., Eguchi, J., and Xu, Z. (2009). Transcriptional targets in adipocyte biology. Expert Opin. Ther. Targets 13, 975-986. DOI |
37 | Rosen, E.D., Hsu, C.H., Wang, X., Sakai, S., Freeman, M.W., Gonzalez, F.J., and Spiegelman, B.M. (2002). C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 16, 22-26. DOI |
38 | Saladin, R., Fajas, L., Dana, S., Halvorsen, Y.D., Auwerx, J., and Briggs, M. (1999). Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis. Cell Growth Differ. 10, 43-48. |
39 | Sarjeant, K. and Stephens, J.M. (2012). Adipogenesis. Cold Spring Harb. Perspect. Biol. 4, a008417. DOI |
40 | Scheffzek, K. and Welti, S. (2012). Pleckstrin homology (PH) like domains - versatile modules in protein-protein interaction platforms. FEBS Lett. 586, 2662-2673. DOI |
41 | Son, H.E., Min, H.Y., Kim, E.J., and Jang, W.G. (2020). Fat mass and obesityassociated (FTO) stimulates osteogenic differentiation of C3H10T1/2 cells by inducing mild endoplasmic reticulum stress via a positive feedback loop with p-AMPK. Mol. Cells 43, 58-65. DOI |
42 | Tanaka, T., Yoshida, N., Kishimoto, T., and Akira, S. (1997). Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 16, 7432-7443. DOI |
43 | Tong, Q., Dalgin, G., Xu, H., Ting, C.N., Leiden, J.M., and Hotamisligil, G.S. (2000). Function of GATA transcription factors in preadipocyte-adipocyte transition. Science 290, 134-138. DOI |
44 | Tontonoz, P., Hu, E., Graves, R.A., Budavari, A.I., and Spiegelman, B.M. (1994). mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev. 8, 1224-1234. DOI |
45 | Waite, K.J., Floyd, Z.E., Arbour-Reily, P., and Stephens, J.M. (2001). Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes. J. Biol. Chem. 276, 7062-7068. DOI |
46 | Wu, Z., Bucher, N.L., and Farmer, S.R. (1996). Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids. Mol. Cell. Biol. 16, 4128-4136. DOI |
47 | Wu, Z., Rosen, E.D., Brun, R., Hauser, S., Adelmant, G., Troy, A.E., McKeon, C., Darlington, G.J., and Spiegelman, B.M. (1999). Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3, 151-158. DOI |
48 | Yu, J., Yun, H., Shin, B., Kim, Y., Park, E.S., Choi, S., Yu, J., Amarasekara, D.S., Kim, S., Inoue, J., et al. (2016). Interaction of tumor necrosis factor receptorassociated factor 6 (TRAF6) and Vav3 in the receptor activator of nuclear factor kappaB (RANK) signaling complex enhances osteoclastogenesis. J. Biol. Chem. 291, 20643-20660. DOI |
49 | Xiao, H. and Jeang, K.T. (1998). Glutamine-rich domains activate transcription in yeast Saccharomyces cerevisiae. J. Biol. Chem. 273, 22873-22876. DOI |
50 | Yamagata, K., Daitoku, H., Shimamoto, Y., Matsuzaki, H., Hirota, K., Ishida, J., and Fukamizu, A. (2004). Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J. Biol. Chem. 279, 23158-23165. DOI |